Abstract:NF-kappa B-controlled transcriptional regulation plays a central role in inflammatory and immune responses. Currently, understanding about NF-kappa B activation mechanism emphasizes I kappa B-tethered complex inactivation in the cytoplasm. In the case of NF-kappa B activation, I kappa B phosphorylation leads to its degradation, followed by NF-kappa B relocation to the nucleus and trans-activation of NF-kappa B-targeted genes. Pretranslational mechanism mediated NF-kappa B activation remains poorly understood. In this study, we investigated NF-kappa B pretranslational regulation by performing a series of database mining analyses and using six large national experimental databases (National Center of Biotechnology Information UniGene expressed sequence tag profile database, Gene Expression Omnibus database, Transcription Element Search System database, AceView database, and Epigenomics database) and TargetScan software. We reported the following findings: 1) NF-kappa B-signaling genes are differentially expressed in human and mouse tissues; 2) heart and vessels are the inflammation-privileged tissues and less easy to be inflamed because lacking in key NF-kappa B-signaling molecular expression; 3) NF-kappa B-signaling genes are induced by cardiovascular disease risk factors oxidized phospholipids and proinflammatory cytokines in endothelial cells; 4) transcription factors CCAAT/enhancer-binding proteins and NF-kappa B have higher binding site frequencies in the promoters of proinflammatory cyto-kine-induced NF-kappa B genes; 5) most NF-kappa B-signaling genes have multiple alternative promoters and alternatively spliced isoforms; 6) NF-kappa B family genes can be regulated by DNA methylation; and 7) 27 of 38 NF-kappa B-signaling genes can be regulated by microRNAs. Our findings provide important insight into the mechanism of NF-kappa B activation, which may contribute to cardiovascular disease, inflammatory diseases, and immunological disorders.

Role of nuclear factor kappa B in the pathogenesis of chronic obstructive pulmonary diseases

Progress in Research in Nuclear Factor-_κB and Coronary Heart Disease

EXPRESSION OF NUCLEAR FACTOR-κB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Nuclear factor-kappa B and its role in inflammatory lung disease

Expression of NF-κB and HIF-1 in PBMC of Patients with Chronic Obstructive Pulmonary Disease

Over-expression of Nuclear Factor-Κb Family Genes and Inflammatory Molecules is Related to Chronic Obstructive Pulmonary Disease

The Role of Nuclear Factor of Activated T Cells in the Process of Pulmonary Diseases Development

Role of IL-6 and NF-kappaB in Patients with Chronic Obstructive Pulmonary Disease

Potential Role of Nuclear Factor κB in Cardiovascular Disease: An Update

Role and Mechanisms of the NF-ĸB Signaling Pathway in Various Developmental Processes

NK Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease

Expression of Nuclear Factor-Κb in the Diabetic Renal Tissue and Intervened Therapy

Involvement of NF- Κb in the Development of Neuropathic Pain

Activation of Hypoxia-Inducible Factor-1 Alpha Via Nuclear Factor-Kappa B in Rats with Chronic Obstructive Pulmonary Disease

Relationship between nuclear factor-κB and pathogenesy of bronchial asthma and its clinical significance

[Role of Glucocorticoid Receptor and Nuclear Factor-Kappab in Patients with Stable Chronic Obstructive Pulmonary Disease].

The role of NF-κB in diabetic cardiomyopathy

Identification of Novel Pretranslational Regulatory Mechanisms for NF-κB Activation.

NF-κB and Acute Pancreatitis

The Role of Innate Immune in the Pathogenesis of Chronic Obstructive Pulmonary Disease

Nuclear Factor Kappa-B and the Heart